Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
There is an urgent need to understand the outcomes of COVID-19 infected patients who undergo surgery, specially vascular surgery. Capturing real-world data and sharing Spanish national experience will inform the management of this complex group of patients who undergo surgery throughout the COVID-19 pandemic, improving their clinical care. The global community has recognised that rapid dissemination and completion of studies in COVID-19 infected patients is a high priority, so we encourage all stakeholders (local investigators, ethics committees, IRBs) to work as quickly as possible to approve this project. This investigator-led, non-commercial, non-interventional study is extremely low risk, or even zero risk. This study does not collect any patient identifiable information (including no dates) and data will not be analysed at hospital-level.
Description: 30-days mortality after vascular surgery in patients with COVID-19 infection
Measure: 30-days mortality Time: 30-daysDescription: 7-days mortality after vascular surgery in patients with COVID-19 infection
Measure: 7-days mortality Time: 7-daysDescription: 30-days reoperation after vascular surgery in patients with COVID-19 infection
Measure: 30-days reoperation Time: 30-daysDescription: Postoperative ICU admission after vascular surgery in patients with COVID-19 infection
Measure: Postoperative ICU admission Time: 30-daysDescription: Postoperative respiratory failure after vascular surgery in patients with COVID-19 infection
Measure: Postoperative respiratory failure Time: 30-daysDescription: Postoperative acute respiratory distress syndrome (ARDS) after vascular surgery in patients with COVID-19 infection
Measure: Postoperative acute respiratory distress syndrome (ARDS) Time: 30-daysDescription: Postoperative sepsis after vascular surgery in patients with COVID-19 infection
Measure: Postoperative sepsis Time: 30-daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports